Cohort1: dose level 1
|
Administration route |
intravenous infusion |
Dosage |
CAdVEC: 5E9, HER2 CAR-T cells: 0 |
Age |
Adult, Older_Adult |
References |
PMID:
36989357
|
|
Cohort2: dose level 2
|
Administration route |
intravenous infusion |
Dosage |
CAdVEC: 1E10, HER2 CAR-T cells: 0 |
Age |
Adult, Older_Adult |
References |
PMID:
36989357
|
|
Cohort3: dose level 3
|
Administration route |
intravenous infusion |
Dosage |
CAdVEC: 1E10, HER2 CAR-T cells: 1E6 |
Age |
Adult, Older_Adult |
References |
PMID:
36989357
|
|
Cohort4: dose level 4
|
Administration route |
intravenous infusion |
Dosage |
CAdVEC: 1E11, HER2 CAR-T cells: 1E6 |
Age |
Adult, Older_Adult |
References |
PMID:
36989357
|
|
Cohort5: dose level 5
|
Administration route |
intravenous infusion |
Dosage |
CAdVEC: 1E10, HER2 CAR-T cells: 1E7 |
Age |
Adult, Older_Adult |
References |
PMID:
36989357
|
|
Cohort6: dose level 6
|
Administration route |
intravenous infusion |
Dosage |
CAdVEC: 1E12, HER2 CAR-T cells: 1E7 |
Age |
Adult, Older_Adult |
References |
PMID:
36989357
|
|
Cohort7: dose level 7
|
Administration route |
intravenous infusion |
Dosage |
CAdVEC: 1E12, HER2 CAR-T cells: 1E8 |
Age |
Adult, Older_Adult |
References |
PMID:
36989357
|
|